Literature DB >> 10512399

Protein hydrolysate formula maintains homeostasis of plasma amino acids in preterm infants.

W A Mihatsch1, F Pohlandt.   

Abstract

BACKGROUND: Plasma amino acid concentrations were measured in preterm infants who were fed either a new hydrolyzed cow's milk protein formula or a standard preterm infant formula. It was hypothesized that feeding with the hydrolysate results in preprandial amino acid concentrations that are significantly different from the concentrations found when feeding with the standard formula.
METHODS: Fifteen preterm infants, median gestational age, 29 weeks (range, 24-32 weeks); birth weight, 1241 g (range, 660-1900 g); and postnatal age, 18 days (range, 7-54 days) receiving full enteral feedings (>150 ml/kg x day), were enrolled. The intervention was randomized allocation to the formula with hydrolyzed or natural cow's milk protein (the whey/casein ratio was 60:40 in both formulas). In a crossover design, each formula was fed for 5 days, and plasma amino acids were analyzed on day 4 or 5 of each 5-day period.
RESULTS: In spite of the 12% higher amino acid intake with hydrolysate formula, the median individual plasma amino acid concentrations were virtually identical with both formulas, and they were within the 10th and the 90th percentile of the reference of levels in the umbilical cord artery after elective cesarean delivery or of breast-fed newborn infants. The median concentrations of lysine and aspartic acid were higher with hydrolyzed formula feeding (p<0.05; two-tailed Mann-Whitney test). With both formulas, single amino acid concentrations were out of the reference values.
CONCLUSION: Virtually identical plasma amino acid concentration patterns were measured with the new hydrolyzed preterm infant formula and the standard preterm infant formula, but longitudinal studies are required before the studied protein hydrolysate can be recommended for preterm feeding in general.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512399     DOI: 10.1097/00005176-199910000-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Effect of protein hydrolysis on the dialysability of amino acids and minerals in infant formulas.

Authors:  F Pérez-Llamas; J F Marín; E Larqué; M Garaulet; S Zamora
Journal:  J Physiol Biochem       Date:  2003-03       Impact factor: 4.158

Review 2.  Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  Protein hydrolysate versus standard formula for preterm infants.

Authors:  Derek Hang Cheong Ng; Joel Rl Klassen; Nicholas D Embleton; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-07-24

4.  Shorter Time to Full Preterm Feeding Using Intact Protein Formula: A Randomized Controlled Trial.

Authors:  Maria Elisabetta Baldassarre; Antonio Di Mauro; Margherita Fanelli; Manuela Capozza; Jennifer L Wampler; Timothy Cooper; Nicola Laforgia
Journal:  Int J Environ Res Public Health       Date:  2019-08-14       Impact factor: 3.390

5.  Infant formulas containing hydrolysed protein for prevention of allergic disease.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

6.  Application effect of extensively hydrolyzed milk protein formula and follow-up in preterm children with a gestational age of less than 34 weeks: study protocol for a randomized controlled trial.

Authors:  Li-Ping Yin; Li-Juan Qian; Huan Zhu; Yan Chen; Han Li; Ji-Nan Han; Li-Xing Qiao
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279

7.  Use of extensively hydrolysed formula for refeeding neonates postnecrotising enterocolitis: a nationwide survey-based, cross-sectional study.

Authors:  Alexandre Lapillonne; Maroun Matar; Ariane Adleff; Marwa Chbihi; Elsa Kermorvant-Duchemin; Florence Campeotto
Journal:  BMJ Open       Date:  2016-07-07       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.